Cardiac Fibrosis Is a Risk Factor for Severe COVID-19

URN to cite this document:: urn:nbn:de:bvb:355-epub-515356
DOI to cite this document:: 10.5283/epub.51535

Mustroph, Julian

; Hupf, Julian

; Baier, Maria J. ; Evert, Katja

; Brochhausen, Christoph

; Broeker, Katharina A. E.

; Meindl, Christine

; Seither, Benedikt ; Jungbauer, Carsten G. ; Evert, Matthias ; Maier, Lars S. ; Wagner, Stefan

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 27 Jan 2022 15:46

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Increased left ventricular fibrosis has been reported in patients hospitalized with coronavirus disease 2019 (COVID-19). It is unclear whether this fibrosis is a consequence of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection or a risk factor for severe disease progression. We observed increased fibrosis in the left ventricular myocardium of deceased COVID-19 patients, ...